Jane Street’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,800
Closed -$111K 12369
2025
Q4
$111K Sell
15,800
-23,200
-59% -$140K ﹤0.01% 10133
2025
Q3
$215K Buy
+39,000
New +$191K ﹤0.01% 9546
2025
Q2
Sell
-56,600
Closed -$377K 10331
2025
Q1
$377K Buy
56,600
+23,200
+69% +$176K ﹤0.01% 7405
2024
Q4
$246K Sell
33,400
-54,800
-62% -$393K ﹤0.01% 8063
2024
Q3
$617K Buy
88,200
+61,000
+224% +$367K ﹤0.01% 6824
2024
Q2
$134K Buy
27,200
+2,700
+11% +$16.3K ﹤0.01% 8628
2024
Q1
$151K Buy
+24,500
New +$165K ﹤0.01% 8340
2022
Q1
Sell
-19,400
Closed -$185K 10703
2021
Q4
$185K Sell
19,400
-38,100
-66% -$404K ﹤0.01% 8870
2021
Q3
$834K Buy
+57,500
New +$1.11M ﹤0.01% 6272

Other funds holding LFST

Jane Street's LFST Position: Q4 2025 in Review

Jane Street sold out of Lifestance Health (LFST) in Q4 2025, closing a stake of 65,745 shares — an estimated $397K sold.

Jane Street first reported a position in LFST in Q4 2021 and held it in 13 quarters. The position peaked at $938K in Q2 2024. 204 funds tracked by Wall St. Rank hold LFST as of Q4 2025.

  • Jane Street reported no remaining Lifestance Health position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 65,745 Lifestance Health shares in Q4 2025, an estimated $397K.
  • Jane Street first reported a position in Lifestance Health in Q4 2021 and held it in 13 quarters.
  • Jane Street's Lifestance Health position peaked at $938K in Q2 2024.
  • 204 funds tracked by Wall St. Rank held Lifestance Health as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.